Explore our materials

Filters

Results (3208)

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Efficacy and Safety of the Once-Daily Darunavir /Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Single-Tablet Regimen in Antiretroviral Treatment (ART)-Experienced and ART-Naïve Women Living with HIV-1: EMERALD and AMBER Week 96 Results

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Week 48 Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Women in the BRIGHTE Study

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Tenofovir Alafenamide vs. Tenofovir DF in Women: Pooled Analysis of 7 Clinical Trials

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Efficacy of Two-Drug Regimen of Dolutegravir Plus Lamivudine (DTG+3TC) Versus Dolutegravir Plus Tenofovir/Emtricitabine (DTG+TDF/FTC) at 48 Weeks in Antiretroviral Naïve Women: GEMINI Studies Subgroup Analysis

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Early Antenatal Care Visit as it Relates to Prevention of Mother to Child Transmission of HIV in Sub-Saharan Africa

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Adoption of an HIV-Neutral Approach to Pregnancy Care in San Francisco, California

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Adverse Pregnancy Outcomes in HIV-Positive Pregnant Women on ART in Kenya

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Lopinavir (an HIV Protease Inhibitor) Impairs Uterine Remodeling During Pregnancy

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Double-Dose Levonorgestrel Implant Does Not Fully Overcome Drug-Drug Interaction with Efavirenz

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Altered Levels of Bioactive Lipids in HIV and cART-Exposed Pregnancy

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Women’s Involvement in Clinical Research: Women Included in Dolutegravir Clinical Trials Versus Collaborative Studies

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

Efficacy and Safety of the Once-Daily Darunavir /Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Single-Tablet Regimen in Antiretroviral Treatment (ART)-Experienced and ART-Naïve Women Living with HIV-1: EMERALD and AMBER Week 96 Results

Week 48 Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Women in the BRIGHTE Study

Tenofovir Alafenamide vs. Tenofovir DF in Women: Pooled Analysis of 7 Clinical Trials

Efficacy of Two-Drug Regimen of Dolutegravir Plus Lamivudine (DTG+3TC) Versus Dolutegravir Plus Tenofovir/Emtricitabine (DTG+TDF/FTC) at 48 Weeks in Antiretroviral Naïve Women: GEMINI Studies Subgroup Analysis

Early Antenatal Care Visit as it Relates to Prevention of Mother to Child Transmission of HIV in Sub-Saharan Africa

Adoption of an HIV-Neutral Approach to Pregnancy Care in San Francisco, California

Adverse Pregnancy Outcomes in HIV-Positive Pregnant Women on ART in Kenya

Lopinavir (an HIV Protease Inhibitor) Impairs Uterine Remodeling During Pregnancy

Double-Dose Levonorgestrel Implant Does Not Fully Overcome Drug-Drug Interaction with Efavirenz

Altered Levels of Bioactive Lipids in HIV and cART-Exposed Pregnancy

Women’s Involvement in Clinical Research: Women Included in Dolutegravir Clinical Trials Versus Collaborative Studies

Vaginal Microbiome and Associations with Tenofovir Diphosphate and Lamivudine Triphosphate in Cervical Tissues of Ugandan Women